vaginal estriol creamAims To quantify estriol serum concentrations in "new" and "chronic users" of topical estriol cream using quantitative liquid chromatography tandem mass spectrometry. Methods In this singlecentre prospective observational study, postmenopausal women with urogynaecological complaints were ...
Vaginal estriol creampharmacodynamicspharmacokineticsestriol concentrationsAim: To establish the pharmacokinetic profile of serum estriol (E3 ) concentrations over 24-hours following application of vaginal E3 in chronic users (>12 weeks of E3 use). The interindividual and intraindividual differences before ...
Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol. 1997;71(1):73-80.Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream ...
Analytic method to determine the estriol concentration of a vaginal creamWe developed a fast, simple and reliable method to determine the concentration of estriol from a cream with several components. Because estriol dissolves well in the methanol, the method showed a very good recovery rate of ...
We aimed to compare the vaginalmicrobiota of postmenopausal women, before and 12 weeks after vaginal estrogen cream. Methods: A total of 44 paired samples from 22 postmenopausal women with vaginal atrophy and stress incontinence were collected pre-vaginal estrogens and were c...
While topical oestrogen has beneficial effects on vaginal health in postmenopausal women, its effects in pre-menopausal women are uncertain. This randomised controlled trial evaluated thickening and maturation effects of estriol cream on vaginal epithelium and changes in microflora in premenopausal women....
Weber MA, Lim V, Oryszczyn J, et al. The effect of vaginal oestriol cream on subjective and objective symptoms of stress urinary incontinence and vaginal atrophy: An international multi-centre pilot study[ J]. Gynecol Obstet Invest, 2017, 82(1): 15-21....
Postmenopausal women with SUI were treated with topical oestriol cream for 6 weeks. The primary subjective outcome was the Patient's Global Impression of Improvement (PGI-I) scale. The primary objective outcome was vaginal pH. Secondary subjective outcomes were: the International Consultation on ...
GYNECOLg Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophyHospital, ElkerliekNetherhmds, TheHo, Dreehtsteden
A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Acta Obstet Gynecol Scand 1983b;62:397-401. B12Mattsson LA, Cullberg G. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Acta Ob- stet ...